Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Leadiant Biosciences S.p.A.

Headquarters: Rome, Italy
Year Founded: 1957
Status: Private

BioCentury | May 17, 2022
Finance

Indaco adds to Italian ecosystem with launch of first dedicated biotech fund

Firm raises €95M at first close, with €150M target for Italian biotechs
BioCentury | Oct 26, 2018
Clinical News

Leadiant gets Priority Review voucher

BioCentury | Oct 12, 2018
Clinical News

FDA approves Leadiant therapy for ADA-SCID

BioCentury | Oct 8, 2018
Company News

FDA approves Leadiant therapy for ADA-SCID

BioCentury | Jun 13, 2018
Distillery Therapeutics

Cancer

BioCentury | Apr 17, 2018
Distillery Therapeutics

Ophthalmic disease

BioCentury | May 9, 2017
Politics & Policy

PhRMA revises eligibility criteria, cutting membership

Items per page:
1 - 9 of 9